Tudor Investment Corp’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Buy |
53,139
+30,665
| +136% | +$1.11M | ﹤0.01% | 899 |
|
|
2025
Q1 | $814K | Buy |
+22,474
| New | +$814K | ﹤0.01% | 1074 |
|
|
2024
Q4 | – | Sell |
-54,496
| Closed | -$3.03M | – | 1999 |
|
|
2024
Q3 | $3.03M | Buy |
54,496
+19,933
| +58% | +$1.11M | 0.01% | 610 |
|
|
2024
Q2 | $1.42M | Buy |
+34,563
| New | +$1.42M | 0.01% | 857 |
|
|
2023
Q3 | – | Sell |
-36,919
| Closed | -$1.7M | – | 1860 |
|
|
2023
Q2 | $1.7M | Sell |
36,919
-548
| -1% | -$25.3K | 0.02% | 707 |
|
|
2023
Q1 | $1.5M | Buy |
+37,467
| New | +$1.5M | 0.02% | 753 |
|
|
2022
Q4 | – | Sell |
-35,729
| Closed | -$1.48M | – | 1899 |
|
|
2022
Q3 | $1.48M | Buy |
35,729
+19,338
| +118% | +$801K | 0.03% | 633 |
|
|
2022
Q2 | $978K | Buy |
+16,391
| New | +$978K | 0.03% | 820 |
|
|
2022
Q1 | – | Sell |
-4,430
| Closed | -$373K | – | 1884 |
|
|
2021
Q4 | $373K | Sell |
4,430
-31,359
| -88% | -$2.64M | 0.01% | 1257 |
|
|
2021
Q3 | $3.23M | Buy |
35,789
+19,932
| +126% | +$1.8M | 0.05% | 374 |
|
|
2021
Q2 | $1.51M | Buy |
+15,857
| New | +$1.51M | 0.03% | 643 |
|
|
2021
Q1 | – | Sell |
-17,712
| Closed | -$2.45M | – | 1768 |
|
|
2020
Q4 | $2.45M | Buy |
17,712
+1,727
| +11% | +$239K | 0.07% | 334 |
|
|
2020
Q3 | $1.31M | Buy |
15,985
+5,318
| +50% | +$437K | 0.06% | 467 |
|
|
2020
Q2 | $834K | Buy |
+10,667
| New | +$834K | 0.04% | 528 |
|
|
2019
Q4 | – | Sell |
-14,214
| Closed | -$608K | – | 1335 |
|
|
2019
Q3 | $608K | Buy |
+14,214
| New | +$608K | 0.02% | 645 |
|
|
2017
Q2 | – | Sell |
-6,343
| Closed | -$430K | – | 1303 |
|
|
2017
Q1 | $430K | Buy |
+6,343
| New | +$430K | 0.01% | 762 |
|
|
2015
Q4 | – | Sell |
-2,441
| Closed | -$235K | – | 1648 |
|
|
2015
Q3 | $235K | Buy |
+2,441
| New | +$235K | 0.01% | 1179 |
|